Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=64

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00089791-cc35e52b",
        "title": "Denosumab 60 mg Q6M vs Placebo: Number of Participants With New Vertebral Fractures",
        "summary": "86 of 3702 against 264 of 3691; risk difference -4.8 points, 95% interval -5.8 to -3.9; NCT00089791, A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis",
        "record": "/library/comparisons/NCT00089791-cc35e52b",
        "nct_id": "NCT00089791",
        "kind": "outcome",
        "participants": 7393,
        "risk_difference": {
          "value": -0.04829464577276395,
          "lower": -0.05809498967619303,
          "upper": -0.038762789980354206
        },
        "group_1": "86 of 3,702",
        "group_2": "264 of 3,691",
        "difference": "-4.8 points",
        "interval": "-5.8 to -3.9",
        "trial_title": "A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis"
      },
      {
        "id": "NCT00563381-sae",
        "title": "Tiotropium vs Salmeterol: serious adverse events",
        "summary": "545 of 3707 against 606 of 3669; risk difference -1.8 points, 95% interval -3.5 to -0.2; NCT00563381, Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.",
        "record": "/library/comparisons/NCT00563381-sae",
        "nct_id": "NCT00563381",
        "kind": "serious-adverse-events",
        "participants": 7376,
        "risk_difference": {
          "value": -0.018148467651198458,
          "lower": -0.03472050308503635,
          "upper": -0.0015814918356620508
        },
        "group_1": "545 of 3,707",
        "group_2": "606 of 3,669",
        "difference": "-1.8 points",
        "interval": "-3.5 to -0.2",
        "trial_title": "Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients."
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=65",
  "request_id": "6glK4EOa8Ii7WgRY"
}